Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05504577Phase 4Completed
Phase 4, randomised trial (3 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Total Blood Loss at 4 days. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05504577.